The Science is Clear: Exercise Still Matters GLP-1 meds for weight loss work, they dont replace everything
If UnitedHealthcare wont cover Wegovy, there are still ways you can save at the pharmacy
As of July 2024, we found 3 studies recruiting participants for addiction-related conditions
As a triple agonist, retatrutide stimulates three potent hormone receptors that control energy balance, metabolism, and weight: Glucagon-Like Peptide-1, or GLP-1: Diminishes appetite Delays the emptying of the stomach Enhances blood sugar regulation Glucose-Dependent Insulinotropic Polypeptide, or GIP: Improves the response to insulin Promotes metabolic adaptability Enhances the use of nutrients The glucagon receptor: Raises energy costs Encourages the burning of fat Aids in the mobilization of fat reserves Compared to single-agonist or dual-agonist therapies, the synergistic effect of these triple agonists results in more effective and long-lasting weight loss
however, full details have not yet been announced, including what the cost of the recommended 25 mg maintenance dose will be and whether there are any limitations on the initial $149 price.